Tibet Rhodiola Pharmaceutical (600211.SHG) Q2 2024 Earnings

Apr 27Confirmed
Oct 2021
Mar 2022
Apr 2022
Q2 2024
-0.85
-0.33
0.19
0.7

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Tibet Rhodiola Pharmaceutical⁩ (⁦600211.SHG⁩) will report earnings of for ⁦Q2 2024⁩ on April 27, 2024.

0 Comments

Share your thoughts